Liquid biopsy is a revolutionary technology that utilizes non-solid biomolecules, such as blood and urine, for the detection and analysis of chronic diseases like cancer. Liquid Biopsy is a cutting-edge diagnostic procedure that uses a quick blood test to non-invasively identify graft rejection at an early stage.
This non-invasive method collects liquid biomarkers that contain fragments shed by tumors, making the sample collection process simple and less risky compared to traditional tissue biopsy. The analysis of these liquid biomarkers, such as ctDNA and cfDNA, allows for a more comprehensive understanding of the tumor.